Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
Clinical trial NCT05103423 · COMPLETED
Trial details
- NCT number
- NCT05103423
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-24
- Primary completion
- 2023-07-07
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.